A clinical research study for Parkinson’s Disease (PD)
Summary
A clinical research study to evaluating the safety and effectiveness of an
investigational drug(BIIB122) in study participants diagnosed with early-stage Parkinson’s Disease(PD)
Eligibility
Eligible gender: Male, Female
Eligible ages: 30 to 80
Inclusion criteria:
You may be eligible to participate in this trial if you are:
- 30 to 80 years of age
- have been diagnosed with Parkinson’s Disease (PD)
Doctors will also evaluate other criteria to make sure you qualify for the study.
Exclusion criteria:
You may not be eligible to participate in this trial if you:
- have hypersensitivity to BIIB122
- female who is breastfeeding or pregnant
Doctors will also evaluate other criteria to make sure you qualify for the study.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Please contact Dr. Camila Aquino at 403) 220-8679 or camila.aquino@ucalgary.ca or study coordinator Carolina De La Rosa Jaimes at carolina.delarosa1@ucalgary.ca if you would like to learn more about this trial.
Principal investigator:
Camila Aquino
Clinical trial:
Yes
REB-ID:
REB22-0363